Different molecular mechanisms have been identified as inducers of GvHD, including the CD95–CD95 ligand, whose accumulation of CD95 ligand, observed through histological techniques, is involved in host tissue damage [12]. The gene discussed is FAS; the disease is graft versus host disease.